Jazz Pharmaceuticals Insider Sold Shares Worth $1,442,820, According to a Recent SEC Filing
Bruce C Cozadd, Director, on July 01, 2026, sold 6,000 shares in Jazz Pharmaceuticals (JAZZ) for $1,442,820. Following the Form 4 filing with the SEC, Cozadd has control over a total of 366,682 ordinary shares of the company, with 366,682 shares held directly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.